常見の血液学的疾患と出血傾向を有する患者の歯科管理
Maryani Mohamed Rohani1, Aisyah Ahmad Fisal1
1Department of Paediatric Dentistry & Orthodontics, Faculty of Dentistry, Universiti Malaya, Kuala Lumpur, Malaysia.
まとめ
抗凝固剤や抗血小板剤の治療を安全かつ効果的に行うために,歯科医は血液学的疾患とその経口症状,例えば出血のリスクを理解しなければなりません.
科学分野:
- 血液学
- 口腔医学
- 歯科 外科
背景:
- 血液学的疾患は,治癒の遅延,潰瘍,出血を含む様々な口腔症状を示します.
- 抗凝固剤と抗血小板剤は頻繁に使用され,歯科治療に影響します.
- 効果的な管理には これらの状態とその治療方法の理解が必要です
研究 の 目的:
- 血液学的な障害の口腔の影響を検討する.
- 抗凝固剤/抗血小板治療を受けている患者の歯科手術の管理戦略を概説する.
- 歯科医と血液専門医の協力を強調する
主な方法:
- 血液学的疾患とその口腔症状に関する文献レビュー
- 歯科における抗凝固剤と抗血小板治療の影響を分析する.
- 診断基準と共同ケアモデルの議論
主要な成果:
- 歯科手術中に出血のリスクが大きく増加します.
- 抗凝固剤/抗血小板治療は,処置前の慎重なリスク評価を必要とします.
- 診断基準を理解することで リスクの高い患者を特定できます
結論:
- 歯科医は,安全な患者のケアのために,血液学的疾患の知識を必要とします.
- リスク評価と管理戦略は,出血障害の患者にとって極めて重要です.
- 歯科と血液学の分野間の連携により 患者の治療成果が向上します
関連する概念動画
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Tonsillitis II: Management
175
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
175
Esophageal Varices-II: Clinical Features and Management
139
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
139
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22


